Porcine brain microvessel endothelial cells show pro-inflammatory response to the size and composition of metallic nanoparticles

Drug Metabolism Reviews

Volumn 46, Issue 2, 2014, Pages 224-231

  Trickler, William J ^a   Lantz Mcpeak, Susan M ^a   Robinson, Bonnie L ^a   Paule, Merle G ^a   Slikker Jr , William ^a   Biris, Alexandru S ^b   Schlager, John J ^c   Hussain, Saber M ^c   Kanungo, Jyotshna ^a   Gonzalez, Carmen ^d   Ali, Syed F ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^c AIR FORCE RESEARCH LABORATORY   (United States)

^d UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

Blood brain barrier; Lipopolysaccharide (LPS); Metallic colloidal nanoparticles; Neuroinflamation; Neurotoxicity; Porcine brain microvessel endothelial cells

Indexed keywords

COPPER NANOPARTICLE; FLUORESCEIN; GOLD NANOPARTICLE; INTERLEUKIN 1BETA; PROSTAGLANDIN E2; SILVER NANOPARTICLE; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; METAL NANOPARTICLE;

ANIMAL CELL; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; CELL MEMBRANE PERMEABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL PIG; IN VITRO STUDY; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PARTICLE SIZE; REVIEW; ANIMAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; ENDOTHELIUM CELL; IMMUNOLOGY; MICROVASCULATURE; NEUROTOXICITY SYNDROMES; SECRETION (PROCESS); SURFACE PROPERTY; SWINE; TOXICITY;

ANIMALS; BLOOD-BRAIN BARRIER; DINOPROSTONE; ENDOTHELIAL CELLS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; METAL NANOPARTICLES; MICROVESSELS; NEUROTOXICITY SYNDROMES; PARTICLE SIZE; SURFACE PROPERTIES; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899413985     PISSN: 03602532     EISSN: 10979883     Source Type: Journal    
DOI: 10.3109/03602532.2013.873450     Document Type: Review

References (43)

1. Abraham CS, Deli MA, Joo F, et al. (1996). Intracarotid tumor necrosis factor-alpha administration increases the blood-brain barrier permeability in cerebral cortex of the newborn pig: Quantitative aspects of double-labelling studies and confocal laser scanning analysis. Neurosci Lett 208: 85-88.
2. Aruoja V, Dubourguier HC, Kasemets K, Kahru A. (2009). Toxicity of nanoparticles of CuO, ZnO and TiO2 to microalgae Pseudokirchneriella subcapitata. Sci Total Environ 407: 1461-1468.
3. Audus KL, Borchardt RT. (1987). Bovine brain microvessel endothelial cell monolayers as a model system for the blood-brain barrier. Ann N Y Acad Sci 507: 9-18.
4. Barone FC, Feuerstein GZ. (1999). Inflammatory mediators and stroke: New opportunities for novel therapeutics. J Cereb Blood Flow Metab 19: 819-834.
5. Bove K, Neumann P, Gertzberg N, Johnson A. (2001). Role of ecNOSderived NO in mediating TNF-induced endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 280:L914-L922.
6. Claudio L, Martiney JA, Brosnan CF. (1994). Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1 beta or tumor necrosis factor-alpha. Lab Invest 70: 850-861.
7. Calingasan NY, Huang PL, Chun HS, et al. (2000). Vascular factors are critical in selective neuronal loss in an animal model of impaired oxidative metabolism. J Neuropathol Exp Neurol 59: 207-217.
8. Deli MA, Descamps L, Dehouck MP, et al. (1995). Exposure of tumor necrosis factor-alpha to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin. J Neurosci Res 41: 717-726.
9. de Vries HE, Blom-Roosemalen MC, van Oosten M, et al. (1996). The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol 64: 37-43.
10. Dobias J, Bernier-Latmani R. (2013). Silver release from silver nanoparticles in natural waters. Environ Sci Technol 47: 4140-4146.
11. Duchini A. (1996). The role of central nervous system endothelial cell activation in the pathogenesis of hepatic encephalopathy. Med Hypotheses 46: 239-244.
12. Ergenekon E, Gucuyener K, Erbas D, et al. (2004). Cerebrospinal fluid and serum vascular endothelial growth factor and nitric oxide levels in newborns with hypoxic ischemic encephalopathy. Brain Dev 26: 283-286.
13. Fiala M, Looney DJ, Stins M, et al. (1997). TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Mol Med 3: 553-564.
14. Fisher M. (2008). Injuries to the vascular endothelium: Vascular wall and endothelial dysfunction. Rev Neurol Dis 5:S4-S11.
15. Franke H, Galla H, Beuckmann CT. (2000). Primary cultures of brain microvessel endothelial cells: A valid and flexible model to study drug transport through the blood-brain barrier in vitro. Brain Res Brain Res Protocol 5: 248-256.
16. Franke H, Galla HJ, Beuckmann CT. (1999). An improved low-permeability in vitro-model of the blood-brain barrier: Transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol. Brain Res 818: 65-71.
17. Gurunathan S, Lee KJ, Kalishwaralal K, et al. (2009). Antiangiogenic properties of silver nanoparticles. Biomaterials 30: 6341-6350.
18. Hartung HP, Jung S, Stoll G, et al. (1992). Inflammatory mediators in demyelinating disorders of the CNS and PNS. J Neuroimmunol 40: 197-210.
19. Kalishwaralal K, Banumathi E, Ram Kumar Pandian S, et al. (2009). Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells. Colloids Surf B Biointerfaces 73: 51-57.
20. Karlsson J, Artursson P. (1992). A new diffusion chamber system for the determination of drug permeability coefficients across the human intestinal epithelium that are independent of the unstirred water layer. Biochim Biophys Acta 1111: 204-210.
21. Mark KS, Trickler WJ, Miller DW. (2001). Tumor necrosis factor-alpha induces cyclooxygenase-2 expression and prostaglandin release in brain microvessel endothelial cells. J Pharmacol Exp Ther 297: 1051-1058.
22. Mayhan WG. (2002). Cellular mechanisms by which tumor necrosis factor-alpha produces disruption of the blood-brain barrier. Brain Res 927: 144-152.
23. Murdock RC, Braydich-Stolle L, Schrand AM, et al. (2008). Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci 101: 239-253.
24. Perry VH, Anthony DC, Bolton SJ, Brown HC. (1997). The bloodbrain barrier and the inflammatory response. Mol Med Today 3: 335-341.
25. Rahman MF, Wang J, Patterson TA, et al. (2009). Expression of genes related to oxidative stress in the mouse brain after exposure to silver- 25 nanoparticles. Toxicol Lett 187: 15-21.
26. Rosas-Hernandez H, Jimenez-Badillo S, Martinez-Cuevas PP, et al. (2009). Effects of 45-nm silver nanoparticles on coronary endothelial cells and isolated rat aortic rings. Toxicol Lett 191: 305-313.
27. Saito K, Suyama K, Nishida K, et al. (1996). Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain. Neurosci Lett 206: 149-152.
28. Schafer B, Brocke JV, Epp A, et al. (2013). State of the art in human risk assessment of silver compounds in consumer products: A conference report on silver and nanosilver held at the BfR in 2012. Arch Toxicol 87: 2249-2262.
29. Shalev H, Serlin Y, Friedman A. (2009). Breaching the blood-brain barrier as a gate to psychiatric disorder. Cardiovasc Psychiatry Neurol 2009:278531 (1-7).
30. Sharma HS, Ali SF, Hussain SM, et al. (2009a). Influence of engineered nanoparticles from metals on the blood-brain barrier permeability, cerebral blood flow, brain edema and neurotoxicity. An experimental study in the rat and mice using biochemical and morphological approaches. J Nanosci Nanotechnol 9: 5055-5072.
31. Sharma HS, Ali SF, Tian ZR, et al. (2009a). Chronic treatment with nanoparticles exacerbate hyperthermia induced blood-brain barrier breakdown, cognitive dysfunction and brain pathology in the rat. Neuroprotective effects of nanowired-antioxidant compound H-290/ 51. J Nanosci Nanotechnol 9: 5073-5090.
32. Sheikpranbabu S, Kalishwaralal K, Venkataraman D, et al. (2009). Silver nanoparticles inhibit VEGF- and IL-1beta-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells. J Nanobiotechnol 7:8 (1-12).
33. Trickler WJ, Lantz SM, Murdock RC, et al. (2010a). Brain microvessel endothelial cells responses to gold nanoparticles: In vitro proinflammatory mediators and permeability. Nanotoxicology 5: 497-492.
34. Trickler WJ, Lantz SM, Murdock RC, et al. (2010b). Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells. Toxicol Sci 118: 160-170.
35. Trickler WJ, Lantz SM, Schrand AM, et al. (2012). The effects of copper nanoparticles on rat cerebral microvessel endothelial cells. Nanomedicine (London) 7: 835-846.
36. Trickler WJ, Mayhan WG, Miller DW. (2005). Brain microvessel endothelial cell responses to tumor necrosis factor-alpha involve a nuclear factor kappa B (NF-kappaB) signal transduction pathway. Brain Res 1048: 24-31.
37. Ujiie M, Dickstein DL, Carlow DA, Jefferies WA. (2003). Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation 10: 463-470.
38. Vadeboncoeur N, Segura M, Al-Numani D, et al. (2003). Proinflammatory cytokine and chemokine release by human brain microvascular endothelial cells stimulated by Streptococcus suis serotype 2. FEMS Immunol Med Microbiol 35: 49-58.
39. Wang J, Rahman MF, Duhart HM, et al. (2009). Expression changes of dopaminergic system-related genes in PC12 cells induced by manganese, silver, or copper nanoparticles. Neurotoxicology 30: 926-933.
40. Wittmaack K. (2011). In search of the most relevant parameter for quantifying lung inflammatory response to nanoparticles exposure: Particle number, surface area, or what? Environ Health Prospect 2011: 187-194.
41. Weber SJ, Abbruscato TJ, Brownson EA, et al. (1993). Assessment of an in vitro blood-brain barrier model using several [Met5]enkephalin opioid analogs. J Pharmacol Exp Ther 266: 1649-1655.
42. Xui Z, Ma J, Alvarez P. (2011). Differential effects of common ligangs and molecular oxygen on antimicrobial activity of silver nanoparticles versus silver ions. Environ Sci Technol 45: 9003-9008.
43. Zhang W, Yao Y, Sullivan N, Chen Y. (2011). Modeling the primary size effects of citrate-coated silver nanoparticles on their ion release kinetics. Environ Health Sci Technol 45: 4422-4428.